NEW YORK, NY – In a candid interview on CBS News yesterday, Martin Shkreli admitted that “Yes, Heather Bresch and I are a**holes.” Mylan CEO Heather Bresch has been on the hot seat recently for her 400% price hike of EpiPens, while former Turing CEO Martin Shkreli made news last year for his 5000% price hike for Daraprim, an antiparasitic agent used in the treatment of toxoplasmosis. Shkreli is currently being indicted for securities fraud. In sum: a**holes.
On a serious and non-satirical note, if you think there should be an investigation into Bresch’s EpiPen price hike, consider signing this Stop the Epipen Price Gouge petition, which is gaining momentum at 100,000+ letters. Thank you!